Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of December 14th – 20th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view the full article.
Following the Merger’s Close, the New Combined Company Will Operate Under the Tilray Name With Offices in New York, Seattle, Toronto, Vancouver Island, Leamington, Germany and Portugal
After Several Days of Speculation, Aphria (TSX: APHA) (NYSE: APHA) (FRA: 10E) and Tilray (NASDAQ: TLRY) (FRA: 2HQ) officially announced the two Top Canadian Licensed Producers (LPs) have signed a definitive agreement to merge. The mega-merger would create the world’s largest cannabis operator based on pro-forma revenue, with the combined company having a pro forma equity value of CDN $5 billion.
The Vote is a Product of Activist-Led Efforts By the Group Decriminalize Nature, Which Has Been Pushing Local Legislators to Expand Upon the City’s Current Decriminalization Policy That Was Enacted Last Year
The Oakland City Council on Tuesday unanimously approved a resolution that calls on California state lawmakers to enact policies decriminalizing a wide range of Psychedelics and allowing local jurisdictions to permit healing ceremonies where people could use entheogenic substances.
RWB Made Major Headlines on Thursday Following the Release of Back to Back Blockbuster Press Releases
First, Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) announced the company inked a deal to acquire a 23,572 sq ft active Illinois cultivation and manufacturing operation, along with medical and adult-use THC licenses and the associated inventory and real estate assets, including 2 acres of land. RWB followed up the Illinois news by dropping a second game-changing press release informing investors that the company signed a USD $60 million non-dilutive credit facility term sheet.
The Fund’s Managing Director Karan Wadhera Has Managed to Raise More Cash Just as the Market for Cannabis-Related Products Seems Poised for Another Period of Expansion
Casa Verde Capital, the investment fund co-founded by Cannabis connoisseur Snoop Dogg (also known as Calvin Broadus), has closed on $100 million for its second investment fund, according to documents filed with the SEC.
They Aren’t Called “Magic” Mushrooms For Nothing
The restorative and healing properties of Magic Mushrooms have been recognized for thousands of years, and the Psilocybin found in more than 200 kinds of fungi looks to be the next big thing in functional food.
Sen. Rand Paul (R-KY) Has Introduced a Bill That Would Triple the Concentration of THC That Can Be in Legal Hemp Plants and Address Multiple Other Concerns the Industry Has Expressed About Proposed Federal Hemp Regulations
Hemp and its derivatives were legalized under the 2018 Farm Bill, and the U.S. Department of Agriculture (USDA) quickly got to work developing rules for the market. But industry stakeholders have strongly protested certain restrictive regulations that they say could inhibit the sector’s growth.
Based on Positive Pre-IND Meeting With FDA, MindMed is Now Prepared to Open an Investigational New Drug (IND) in August 2021 With a Phase 2B Clinical Trial for LSD Assisted Therapy in Anxiety
MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ) announced the successful completion of a pre-IND (Investigational New Drug) meeting with the U.S. FDA regarding the development of LSD assisted therapy for an anxiety disorder. MindMed also provided a clinical development update on 18-MC announcing the firm continues to dose escalation of 18-MC in Phase I SAD/MAD and has confirmed a meeting with the FDA.
The Question Now Becomes Whether the Two Chambers Can Reconcile the Pair of Bills and Approve a Final Version Before the Current Congressional Session Ends January 3rd
A bipartisan bill in the U.S. Senate to expand Marijuana and CBD research was approved by the upper chamber on a unanimous voice vote, less than a week after the House of Representatives passed its own MJ research legislation.
It’s Said That Science Progresses “One Gravestone at a Time,” Since Major Changes in Theoretical Perspective Usually Require a New Generation or More to Take Hold
Psychiatry, in contrast, is in the midst of a massive shift: We’re experiencing a veritable Psychedelic revolution, as drugs like MDMA, Psilocybin and Ketamine offer new hope for treating severe mental anguish.
The Measure Now Heads to Gov. Phil Murphy, Who is Expected to Sign the Legislation
Recreational adult-use Marijuana is just a signature away from becoming legal in New Jersey after both houses of the state legislature passed legislation on Thursday to decriminalize and legalize the industry.